title: Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts.
abstract: Preclinical or clinical trials for muscular dystrophies have met with modest success, mainly because of inefficient delivery of viral vectors or donor cells to dystrophic muscles. We report here that intra-arterial delivery of wild-type mesoangioblasts, a class of vessel-associated stem cells, corrects morphologically and functionally the dystrophic phenotype of virtually all downstream muscles in adult immunocompetent alpha-sarcoglycan (alpha-SG) null mice, a model organism for limb-girdle muscular dystrophy. When mesoangioblasts isolated from juvenile dystrophic mice and transduced with a lentiviral vector expressing alpha-SG were injected into the femoral artery of dystrophic mice, they reconstituted skeletal muscle in a manner similar to that seen in wild-type cells. The success of this protocol was mainly due to widespread distribution of donor stem cells through the capillary network, a distinct advantage of this strategy over previous approaches.
authors.affiliation: Stem Cell Research Institute, H. S. Raffaele, Via Olgettina 58, 20132 Milan, Italy.
authors.forename: Maurilio
authors.initials: M
authors.lastname: Sampaolesi
authors.forename: Yvan
authors.initials: Y
authors.lastname: Torrente
authors.forename: Anna
authors.initials: A
authors.lastname: Innocenzi
authors.forename: Rossana
authors.initials: R
authors.lastname: Tonlorenzi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: D'Antona
authors.forename: M Antonietta
authors.initials: MA
authors.lastname: Pellegrino
authors.forename: Rita
authors.initials: R
authors.lastname: Barresi
authors.forename: Nereo
authors.initials: N
authors.lastname: Bresolin
authors.forename: M Gabriella Cusella
authors.initials: MG
authors.lastname: De Angelis
authors.forename: Kevin P
authors.initials: KP
authors.lastname: Campbell
authors.forename: Roberto
authors.initials: R
authors.lastname: Bottinelli
authors.forename: Giulio
authors.initials: G
authors.lastname: Cossu
mesh_terms: D000818:Animals; D001808:Blood Vessels / Q000166:cytology / Q000196:embryology; D002454:Cell Differentiation; D002460:Cell Line; D002465:Cell Movement; D003598:Cytoskeletal Proteins / Q000235:genetics* / Q000378:metabolism*; D016189:Dystrophin / Q000378:metabolism; D004730:Endothelium, Vascular / Q000502:physiology; D005260:Female; D005263:Femoral Artery; D005822:Genetic Vectors; D016086:Lentivirus / Q000235:genetics; D008124:Locomotion; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics* / Q000378:metabolism*; D008648:Mesoderm / Q000166:cytology; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D009119:Muscle Contraction; D018485:Muscle Fibers, Skeletal / Q000166:cytology / Q000502:physiology; D018482:Muscle, Skeletal / Q000166:cytology / Q000378:metabolism / Q000473:pathology / Q000502:physiology*; D009137:Muscular Dystrophy, Animal / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D012038:Regeneration; D049031:Sarcoglycans; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000502:physiology*; D014162:Transfection
chemical_list: D003598:Cytoskeletal Proteins; D016189:Dystrophin; D008562:Membrane Glycoproteins; D049031:Sarcoglycans